Consumer Driven Health Care

Laws designed to equalize out-of-pocket costs faced by cancer patients undergoing chemotherapy whether treated intravenously, with pills or liquid doses are having mixed results, according to new research.

The rise in overall spending within the U.S. health care sector has been muted, due mainly to hospitals trying to control increasing costs.

Big Pharmas efforts to somehow put a lid on the brewing opioid controversy received a major blow in what was once a pharmaceuticals stronghold: Texas.

Federal officials are exploring how beneficiaries could get a share of certain behind-the-scenes fees and discounts negotiated by insurers and pharmacy benefit managers, or PBMs, who together administer Medicares Part D drug program.

One way to ensure employees are receiving the most accurate and helpful information available is to utilize new technology and data segmentation that can help drive informed decision making.

When it comes to price transparency, just seven states earned a passing grade.